Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-12-001596
Filing Date
2012-05-15
Accepted
2012-05-15 14:52:08
Documents
15
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q elgo_10q.htm 10-Q 584122
2 LETTER AGREEMENT elgo_ex1019.htm EX-10.19 9660
3 PROMISSORY NOTE elgo_ex1020.htm EX-10.20 42898
4 LETTER OF INTENT EXTENSION elgo_ex1021.htm EX-10.21 8999
5 CERTIFICATION elgo_ex311.htm EX-31.1 13242
6 CERTIFICATION elgo_ex312.htm EX-31.2 13661
7 CERTIFICATION elgo_ex321.htm EX-32.1 7815
8 CERTIFICATION elgo_ex322.htm EX-32.2 8355
9 img001.jpg GRAPHIC 4217
  Complete submission text file 0001477932-12-001596.txt   1800030

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT elgo-20120331.xml EX-101.INS 115896
11 XBRL TAXONOMY EXTENSION SCHEMA elgo-20120331.xsd EX-101.SCH 14985
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE elgo-20120331_cal.xml EX-101.CAL 30656
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elgo-20120331_def.xml EX-101.DEF 16872
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE elgo-20120331_lab.xml EX-101.LAB 109167
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elgo-20120331_pre.xml EX-101.PRE 73382
Mailing Address 1264 UNIVERSITY AVENUE WEST SUITE 404 ST. PAUL MN 55104
Business Address 1264 UNIVERSITY AVENUE WEST SUITE 404 ST. PAUL MN 55104 5163038181
Enterologics, Inc. (Filer) CIK: 0001483731 (see all company filings)

EIN.: 800504940 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54347 | Film No.: 12843669
SIC: 2834 Pharmaceutical Preparations